港股異動 | 偉祿集團(1196.HK)漲7%續創新高 要約收購先施獲70.24%接納
格隆匯5月10日丨偉祿集團(1196.HK)股價經過前段時間橫盤調整後再度走強,盤中最高見12.44港元續創新高,現報12.36港元,漲幅6.92%,最新總市值177.76億港元。公司此前公佈,以現金要約收購先施有限公司全部已發行股份。5月7日,公司再度發佈公吿稱,要約人已就要約接獲有關合共9.229億股先施股份(相當於公佈日期先施全部已發行股本約70.24%)之有效接納,導致要約人及其一致行動人士於公佈日期持有先施逾50%投票權。因此,要約文件所載之要約條件已獲達成,及要約已於5月7日在所有方面成為無條件。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.